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Background
Regarding the large figures of patients affected with
potentially life-threatening peanut allergy, the possibility
of inevitable occurrence of unexpected exposures and,
the paucity of promising acceptable immunotherapy
approaches, more applicable and at the same time, safe
remedial strategies are necessitated.
Quercetin, a nutritional panacea belonging to “Flavo-
nol” sub-group of the flavonoid family, thanks to its
antioxidant/free radical-scavenging, anti-inflammatory
and other protective properties has been suggested for
therapy of humankind allergic diseases and might be
helpful for the treatment of food allergies.
Objective
The main aim of our study was to investigate the anti-
aanaphylactic characteristics of quercetin in a wistar-rat
model of peanut allergy.
Material and methods
40 male wistar rats, 4-6 weeks old at study start, were
sensitized with crude peanut herape in the presence of
cholera toxin adjuvant. The sensitized rats in the treat-
ment group (n= 10), were treated intragastrically with
quercetin, at a dose of 50 mg/Kg.BW over a period of
four weeks. Subsequently, some well-known anaphy-
laxis-determinant variables were measured.
Results
Following calculations, it was revealed that quercetin has
sufficiently abrogated peanut-induced anaphylactic reac-
tions. Accordingly, plasma histamine and total serum
IgE levels had been lowered significantly, in treatment
group (p< 0.000 and p<0.000, respectively). Additionally,
all of the intradermal- and intraperitoneal-challenge
test-results were negative in the quercetin-treated
animals.
Conclusions
Our results approved that a naturally-occurring flavo-
noid, Quercetin, has been efficient enough to curb the
peanut allergy complications in a wistar model and can
be considered as a secure preventative/prophylactic/
herapeutic compound in populations suffering from
potentially deathful IgE-mediated food allergies.
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